Skip to main content
☰
moat
keep
Markets
News
Screener
Research
Editorials
Pricing
About
⌘K
Sign in
Start free
TENAX THERAPEUTICS, INC. (TENX) stock — financials, valuation and filings | Moatkeep
Companies
/
Nasdaq
/
TENX
TENAX THERAPEUTICS, INC.
TENX · Nasdaq
$1.61
−4.73%
Close, 2026-11-12
Close, 2026-11-12 · source: Databento · USD · figures not investment advice
+ Alert
★ Watchlist
Overview
News
Valuation
Financials
Reports
Editorials & Research
Business
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
MAX
⤢ Expand
Price
▾
Log
Volume
Events
▾
Data under review
Price
ex-date (0) · fiscal quarter (0)
Dividends: company filings (SEC EDGAR) and the historical exchange record.
State of incorporation
DE
Fiscal year end
Dec 31
Financials · latest year
USD millions
FY2025
Revenue
0
Net Income
-53
FY2024
•••••
•••••
FY2023
•••••
•••••
FY2022
•••••
•••••
FY2021
•••••
•••••
Read the full financial statements
Create a free account to see 5 years of financial history
Create a free account
Source: SEC EDGAR (XBRL) · figures in USD millions
View full financials →
Related companies
PYPD
—
PolyPid Ltd.
NMAD
—
NOMAD POWER SOLUTIONS, INC.
CSTE
—
Caesarstone Ltd.
NTIC
—
NORTHERN TECHNOLOGIES INTERNATIONAL CORP
ONCY
—
ONCOLYTICS BIOTECH INC
MX
—
MAGNACHIP SEMICONDUCTOR Corp
LSE
—
Leishen Energy Holding Co., Ltd.
NMRA
—
Neumora Therapeutics, Inc.